Method for the microbiological production of non-antigenic hyalu

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4351721, 4352534, 435885, 536 551, 536124, G12P 1904, G12N 1501, G12N 120

Patent

active

053169263

ABSTRACT:
The present disclosure is concerned with the production of high molecular weight hyaluronic acid suitable for medicinal administration to mammals without provoking an immune response from microbiological fermentation. The cultures may be prepared from specially developed strains of hyaluronic acid generating bacteria obtained by passaging in serologically negative host animal blood. The cultures are kept in log phase growth for an extended period by appropriate temperature, pH and glucose content adjustments. If the cultured strain is not hyaluronidase negative the hyaluronidase activity is inhibited. The hyaluronic acid is precipitated from the culture by the sequential addition of an anionic surfactant and then a cationic surfactant and extended from the precipitate with a high molarity aqueous calcium ion solution. The isolated aqueous hyaluronic acid solution may then be purified by passage through a nitrocellulose filter. Its pyrogenicity may be alleviated by treatment with a strong acid washed activated carbon.

REFERENCES:
patent: 2975104 (1961-03-01), Warren
patent: 3396081 (1968-08-01), Billek
patent: 4007184 (1977-02-01), Cronin
patent: 4141973 (1979-02-01), Balazs
patent: 4303676 (1981-12-01), Balazs
patent: 4328803 (1982-05-01), Pape
patent: 4517295 (1985-05-01), Bracke et al.
patent: 4582798 (1986-04-01), Brown et al.
Bergey's Manual of Determinative Bacteriology, 8th ed, 1974, p. 498.
Leuette et al, "Manual of Clinical Microbiology", 1974, pp. 61-62, ASM.
Infection and Immunity, Feb. 1980, vol. 27, No. pp. 444-448, I Van De Rijn "Growth Characteristics of Group A Streptococci in a New Chemically Defined Medium".
J. Gen. Microbiol. 1974 85 Pt. 2, 375-5 "The Capsule of Streptococcus Equi".
ACTA, Path. Microbiol Scand. Sect. B 84, 162-164, 1976 "Isolation of Hyaluronic Acid from Cultures of Streptococci in a Chemically Defined Medium". (CA 85:16770s vol. 85 1976 also enclosed).
Merck Index, 9th Ed. (3re Printing) 1978, p. 537.
The Doctoral Thesis "The Biosynthesis of Hyaluronate by Group A Streptococcus" J. Ginzburg, 1955.
Van de Rijn, Streptococcal Hyaluronic Acid: Proposed Mechanism of Degradation and Loss of Synthesis During Stationary Phase. J. Bact, vol. 156, pp. 1059-1065, 1983.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for the microbiological production of non-antigenic hyalu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the microbiological production of non-antigenic hyalu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the microbiological production of non-antigenic hyalu will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1627480

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.